PharmaCept is an innovative company based in Berlin. Since 1999, we have been developing and marketing products for the locoregional treatment of tumor diseases worldwide. Our focus is on the treatment of primary and secondary liver and lung tumors as well as non-muscle invasive bladder cancer, NMIBC.

Our products are renowned for their therapeutic efficacy and good tolerability. PharmaCept strives to continuously  improve the therapeutic results and the associated quality of life of its patients.

PharmaCept collaborates with clinics and research institutions to research innovative drugs and methods for the treatment of tumor diseases in order to offer patients the best possible therapy options.